MwanzoME • NASDAQ
23andMe Holding Co.
$ 3.11
Baada ya Saa za Kazi:
$ 3.22
(3.54%)+0.11
Imefungwa: 22 Nov, 18:26:25 GMT -5 · USD · NASDAQ · Kanusho
HisaHisa zinazouzwa MarekaniMakao yake makuu ni Marekani
Bei iliyotangulia
$ 3.23
Bei za siku
$ 2.99 - $ 3.21
Bei za mwaka
$ 2.66 - $ 20.20
Thamani ya kampuni katika soko
74.94M USD
Wastani wa hisa zilizouzwa
elfu 404.88
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(USD)Sep 2024Mabadiliko Tangu Mwaka Uliopita
Mapato
44.07M-11.86%
Matumizi ya uendeshaji wa biashara
81.33M-17.18%
Mapato halisi
-59.10M21.48%
Kiwango cha faida halisi
-134.1110.91%
Mapato kwa kila hisa
EBITDA
-54.96M21.06%
Asilimia ya kodi ya mapato
0.07%
Jumla ya mali
Jumla ya dhima
(USD)Sep 2024Mabadiliko Tangu Mwaka Uliopita
Uwekezaji wa pesa taslimu na vipindi vifupi
126.60M-50.62%
Jumla ya mali
318.94M-60.19%
Jumla ya dhima
217.01M23.31%
Jumla ya hisa
101.93M
hisa zilizosalia
26.12M
Uwiano wa bei na thamani
0.82
Faida inayotokana na mali
-42.89%
Faida inayotokana mtaji
-75.30%
Mabadiliko halisi ya pesa taslimu
(USD)Sep 2024Mabadiliko Tangu Mwaka Uliopita
Mapato halisi
-59.10M21.48%
Pesa kutokana na shughuli
-40.93M28.34%
Pesa kutokana na uwekezaji
-2.70M2.63%
Pesa kutokana na ufadhili
elfu 260.00-83.68%
Mabadiliko halisi ya pesa taslimu
-43.37M25.18%
Mtiririko huru wa pesa
-12.82M59.90%
Kuhusu
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell. Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008. The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
Apr 2006
Wafanyakazi
571
Gundua zaidi
Huenda unavutiwa na
Orodha hii imetokana na maudhui uliyotafuta hivi majuzi, hisa unazofuatilia na shughuli zingine. Pata maelezo zaidi

Data na maelezo yote hutolewa “kama yalivyo” kwa madhumuni ya taarifa binafsi tu, wala hayanuii kuwa ushauri wa kifedha na hayana madhumuni ya kufanya biashara au uwekezaji, kodi, kisheria, uhasibu au ushauri mwingine. Google si mshauri wa uwekezaji wala mshauri wa kifedha na haitoi maoni au mapendekezo yanayohusiana na kampuni zozote zilizojumuishwa kwenye orodha hii au hisa zozote zilizotolewa na kampuni hizo. Tafadhali wasiliana na dalali wako au mwakilishi wa kifedha ili uthibitishe bei kabla ya kufanya biashara yoyote. Pata maelezo zaidi
Watu pia hutafuta
Tafuta
Futa utafutaji
Funga kisanduku cha kutafutia
Programu za Google
Menyu kuu